Biotech

Q BioMed Profiled ON Proactive Investors

Biotech

Q BioMed Inc. (OTCQB:QBIO) was recently featured on Proactive Investors where company CEO, Denis Corin talked about the company looking to the US Food and Drug Administration to sign off on “a new manufacturing facility to produce Strontium Chloride Sr89 injection.”

Q BioMed Inc. (OTCQB:QBIO) was recently featured on Proactive Investors where company CEO, Denis Corin talked about the company looking to the US Food and Drug Administration to sign off on “a new manufacturing facility to produce Strontium Chloride Sr89 injection.”


To watch the full interview, click here.
Click here to connect with Q BioMed and receive an Investor’s Presentation.

Source: www.proactiveinvestors.com

MARKETS

Markets
TSX20725.00+96.08
TSXV621.14+7.54
DOW34156.69+265.67
S&P 5004164.00+52.92
NASD12113.79+226.34
ASX7504.10-34.90

COMMODITIES

Commodities
Gold1877.38+4.44
Silver22.33+0.12
Copper4.080.00
Palladium1713.170.00
Platinum1087.260.00
Oil77.32+0.18
Heating Oil2.91+0.01
Natural Gas2.590.00

DOWNLOAD FREE REPORTS

×